RLX030A

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RLX030A, covering 2020-12-19 to 2020-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF) [Phase 2]